You are here

Metagenomi

5 Life Sciences IPOs in 2023—and the Future Forecast

5 Life Sciences IPOs in 2023—and the Future Forecast

BioSpace

Neumora Therapeutics

Flag link:

New Funding Led by Moderna, Bayer, Brings Metagenomi's Series B to $275M

New Funding Led by Moderna, Bayer, Brings Metagenomi's Series B to $275M

BioSpace

Moderna Therapeutics

Flag link:

Ionis gets into gene editing

Ionis gets into gene editing

EP Vantage

Ionis Pharmaceuticals

Flag link:

Gene editing startup Metagenomi raises $175M to advance research pipeline

Gene editing startup Metagenomi raises $175M to advance research pipeline

BioPharma Dive

Moderna Therapeutics

Flag link:

Moderna finally cracks into gene editing with Metagenomi pact thanks to 'irresistible' data

Moderna finally cracks into gene editing with Metagenomi pact thanks to 'irresistible' data

Fierce Biotech

Moderna Therapeutics

Flag link:

Bayer-backed Metagenomi bumps up series A to $75M as it gears up for gene editing push

Bayer-backed Metagenomi bumps up series A to $75M as it gears up for gene editing push

Fierce Biotech

venture capital

Flag link:

Bayer powers gene-editing startup Metagenomi to $65M A round

Bayer powers gene-editing startup Metagenomi to $65M A round

Fierce Biotech

Flag link: